Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

Código QR

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

Bruno Fonseca-Santos, Maria Palmira Daflon Gremião, Marlus ChorilliDepartment of Drugs and Medicines, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, BrazilAbstract: Alzheimer’s disease is a neurological disorde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fonseca-Santos B, Gremião MP, Chorilli M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/daad045ca03a4fada451c03ac3b94af3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nanotechnology-based drug delivery systems for treatment of oral cancer: a review
por: Calixto G, et al.
Publicado: (2014)

Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery
por: Fonseca-Santos B, et al.
Publicado: (2016)

Nanotechnology-based drug delivery systems and herbal medicines: a review
por: Bonif&aacute;cio BV, et al.
Publicado: (2013)

Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018)

Nanotechnology-based drug delivery systems for control of microbial biofilms: a review
por: Dos Santos Ramos MA, et al.
Publicado: (2018)

Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
por: Gu W, et al.
Publicado: (2013)

Progress in antiretroviral drug delivery using nanotechnology
por: Rama Mallipeddi, et al.
Publicado: (2010)

A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine
por: Jahangirian H, et al.
Publicado: (2017)

Advances in nanocarriers as drug delivery systems in Chagas disease
por: Quijia Quezada C, et al.
Publicado: (2019)

Nanotechnology, from quantum mechanical calculations up to drug delivery
por: Szefler B
Publicado: (2018)

Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
por: Voltan AR, et al.
Publicado: (2016)

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease
por: Woo FY, et al.
Publicado: (2015)

Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
por: Carely Hernandez, et al.
Publicado: (2022)

Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Adewale Oluwaseun Fadaka, et al.
Publicado: (2021)

Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
por: Alexander Vaneev, et al.
Publicado: (2021)

Liposomes and nanotechnology in drug development: focus on oncotargets
por: Kozako T, et al.
Publicado: (2012)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari S, et al.
Publicado: (2019)

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations
por: Guo JW, et al.
Publicado: (2014)

Mucoadhesive electrospun nanofibers for drug delivery systems: applications of polymers and the parameters’ roles
por: Pérez-González GL, et al.
Publicado: (2019)

Prevention and treatment of biofilms by hybrid- and nanotechnologies
por: Kasimanickam RK, et al.
Publicado: (2013)

Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases
por: Li T, et al.
Publicado: (2018)

Liposomes and nanotechnology in drug development: focus on neurological targets
por: Ramos-Cabrer P, et al.
Publicado: (2013)

Liposomes and nanotechnology in drug development: focus on ocular targets
por: Honda M, et al.
Publicado: (2013)

Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment
por: Ma Z, et al.
Publicado: (2019)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng QQ, et al.
Publicado: (2018)

Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
por: Pala R, et al.
Publicado: (2020)

Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics
por: Chen J, et al.
Publicado: (2013)

Neuroinflammation in Alzheimer’s disease
por: Zhang FJ, et al.
Publicado: (2015)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
por: Koppel J, et al.
Publicado: (2014)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai MC, et al.
Publicado: (2015)

Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
por: Mahdi Ftouh, et al.
Publicado: (2021)

Progress of Nanotechnology in Diabetic Retinopathy Treatment
por: Liu Y, et al.
Publicado: (2021)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş O, et al.
Publicado: (2015)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
por: Tavana JP, et al.
Publicado: (2018)

Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
por: Bhatt PC, et al.
Publicado: (2017)

Nanotechnology-based approaches for targeting and delivery of drugs via Hexakis (m-PE) macrocycles
por: Samaneh Pasban, et al.
Publicado: (2021)

Advances in drug delivery via electrospun and electrosprayed nanomaterials
por: Zamani M, et al.
Publicado: (2013)

Adalimumab for the treatment of Crohn&rsquo;s disease
por: Andrea Cassinotti, et al.
Publicado: (2008)

Natalizumab in the treatment of Crohn&rsquo;s disease
por: Danila Guagnozzi, et al.
Publicado: (2008)